miR-181b as a potential molecular target for anticancer therapy of gastric neoplasms

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 5, 2012, Pages 2263-2267

  Guo, Jian Xin ^a   Tao, Qing Song ^b   Lou, Peng Rong ^b   Chen, Xiao Chun ^b   Chen, Jun ^b   Yuan, Guang Bo ^b  

^a The First People Hospital of Ningbo   (China)

^b Department of Hematology Yin Zhou People Hospital   (China)

Author keywords

Anticancer therapeutics; Gastric cancer; MiR 181b; TIMP3

Indexed keywords

MESSENGER RNA; MICRORNA; MIRN181 MICRORNA, HUMAN;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL MOTION; CELL PROLIFERATION; FLOW CYTOMETRY; GENETICS; HUMAN; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH TUMOR; TUMOR CELL CULTURE; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELL MOVEMENT; CELL PROLIFERATION; FLOW CYTOMETRY; HUMANS; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 84867795829     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.5.2263     Document Type: Article

References (20)

1. Asangani IA, Rasheed SA, Nikolova DA, et al (2008). MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene, 27, 2128-36.
2. Bartel DP (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-97.
3. Chen G, Zhu W, Shi D, et al (2010). MicroRNA-181a sensitizes human malignant glioma U87MG cells to radiation by targeting Bcl-2. Oncol Rep, 23, 997-1003.
4. Connolly E, Melegari M, Landgraf P, et al (2008). Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype. Am J Pathol, 173, 856-64.
5. Garzon R, Calin GA, Croce CM (2009). MicroRNAs in Cancer. Annu Rev Med, 60, 167-79.
6. Gu P, Xing X, Tanzer M, et al (2008). Frequent loss of TIMP-3 expression in progression of esophageal and gastric adenocarcinomas. Neoplasia, 10, 563-72.
7. Ji J, Shi J, Budhu A, et al (2009a). MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med, 361, 1437-47.
8. Ji J, Yamashita T, Budhu A, et al (2009b). Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. Hepatology, 50, 472-80.
9. Kasinski AL, Slack FJ (2011). Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer, 11, 849-64.
10. Kim JH, Jung EJ, Lee HS, et al (2009). Comparative analysis of DNA methylation between primary and metastatic gastric carcinoma. Oncol Rep, 21, 1251-9.
11. Krichevsky AM, Gabriely G (2009). miR-21: a small multi-faceted RNA. J Cell Mol Med, 13, 39-53.
12. Leung WK, To KF, Chu ES, et al (2005). Potential diagnostic and prognostic values of detecting promoter hypermethylation in the serum of patients with gastric cancer. Br J Cancer, 92, 2190-4.
13. Lu J, He ML, Wang L, et al (2011). MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2. Cancer Res, 71, 225-33.
14. Mohammed FF, Smookler DS, Taylor SE, et al (2004). Abnormal TNF activity in Timp3-/- mice leads to chronic hepatic inflammation and failure of liver regeneration. Nat Genet, 36, 969-77.
15. Sun T, Yang M, Chen S, et al (2011). The altered expression of MiR-221/-222 and MiR-23b/-27b is associated with the development of human castration resistant prostate cancer. Prostate, 72, 1093-103.
16. Ueda T, Volinia S, Okumura H, et al (2010). Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol, 11, 136-46.
17. Wang B, Hsu SH, Majumder S, et al (2010a). TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3. Oncogene, 29, 1787-97.
18. Wang J, Wang Q, Liu H, et al (2010b). MicroRNA expression and its implication for the diagnosis and therapeutic strategies of gastric cancer. Cancer Lett, 297, 137-43.
19. Wang Y, Yu Y, Tsuyada A, et al (2011). Transforming growth factor-beta regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM. Oncogene, 30, 1470-80.
20. Wu WK, Lee CW, Cho CH, et al (2010). MicroRNA dysregulation in gastric cancer: a new player enters the game. Oncogene, 29, 5761-71.